{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:42:00Z","timestamp":1779104520715,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.nmd.2008.09.008","type":"journal-article","created":{"date-parts":[[2008,11,7]],"date-time":"2008-11-07T21:02:40Z","timestamp":1226091760000},"page":"962-966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Danon disease: A novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expression"],"prefix":"10.1016","volume":"18","author":[{"given":"Claudia","family":"Di Blasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Jarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Blasevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Dassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2008.09.008_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/WNL.31.1.51","article-title":"Lysosomal glycogen storage disease with normal acid maltase","volume":"31","author":"Danon","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2008.09.008_bib2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1212\/01.WNL.0000141858.80738.AA","article-title":"Charcot-Marie-Tooth features and maculopathy in a patient with Danon disease","volume":"63","author":"Lafor\u00eat","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2008.09.008_bib3","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ophtha.2006.02.030","article-title":"Ophthalmic manifestations of Danon disease","volume":"113","author":"Prall","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.nmd.2008.09.008_bib4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35022604","article-title":"Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)","volume":"406","author":"Nishino","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2008.09.008_bib5","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1083\/jcb.137.5.1161","article-title":"Different steady state subcellular distributions of the three splice variants of lysosome-associated membrane protein LAMP-2 are determined largely by the COOH-terminal amino acid residue","volume":"137","author":"Gough","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2008.09.008_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4615-2401-4_7","article-title":"Biogenesis of the lysosomal membrane","volume":"22","author":"Fukuda","year":"1994","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.nmd.2008.09.008_bib7","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1600-0854.2005.00337.x","article-title":"Unifying nomenclature for the isoforms of the lysosomal membrane protein LAMP-2","volume":"6","author":"Eskelinen","year":"2005","journal-title":"Traffic"},{"key":"10.1016\/j.nmd.2008.09.008_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.WNL.0000069460.53438.38","article-title":"Single section Western blot: improving the molecular diagnosis of the muscular dystrophies","volume":"61","author":"Cooper","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2008.09.008_bib9","doi-asserted-by":"crossref","first-page":"18911","DOI":"10.1016\/S0021-9258(18)37369-1","article-title":"Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycan","volume":"263","author":"Carlsson","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2008.09.008_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2008.09.008_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/gad.1048803","article-title":"Pre-mRNA splicing and human disease","volume":"17","author":"Faustino","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.nmd.2008.09.008_bib12","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1182\/blood.V88.5.1841.1841","article-title":"Two-exon skipping due to a point mutation in p67-phox-deficient chronic granulomatous disease","volume":"88","author":"Aoshima","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.nmd.2008.09.008_bib13","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1093\/nar\/15.17.7155","article-title":"RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression","volume":"15","author":"Shapiro","year":"1987","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2008.09.008_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1101\/gad.7.3.407","article-title":"The role of exon sequences in splice site selection","volume":"7","author":"Watakabe","year":"1993","journal-title":"Genes Dev"},{"key":"10.1016\/j.nmd.2008.09.008_bib15","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1016\/j.febslet.2006.07.018","article-title":"NF1 mRNA biogenesis: effect of the genomic milieu in splicing regulation of the NF1 exon 37 region","volume":"580","author":"Baralle","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nmd.2008.09.008_bib16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/nar\/20.6.1201","article-title":"Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene","volume":"20","author":"Steingrimsdottir","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2008.09.008_bib17","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1006\/bbrc.1995.2528","article-title":"An alternatively spliced form of the human lysosome-associated membrane protein-2 gene is expressed in a tissue-specific manner","volume":"215","author":"Konecki","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nmd.2008.09.008_bib18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0960-8966(03)00105-6","article-title":"Characterization of Danon disease in a male patient and his affected mother","volume":"13","author":"Sugie","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2008.09.008_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0960-8966(94)90025-6","article-title":"Lysosomal glycogen storage with normal acid maltase: a familial study with successful heart transplant","volume":"4","author":"Dworzak","year":"1994","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2008.09.008_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/mus.20471","article-title":"Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease","volume":"33","author":"Echaniz-Laguna","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2008.09.008_bib21","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/WNL.58.12.1773","article-title":"Clinicopathological features of genetically confirmed Danon disease","volume":"58","author":"Sugie","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2008.09.008_bib22","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.105.546481","article-title":"Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children","volume":"112","author":"Yang","year":"2005","journal-title":"Circulation"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896608006196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896608006196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:57:17Z","timestamp":1760774237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896608006196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0960896608006196"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2008.09.008","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Danon disease: A novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expression","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2008.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}